Trial · NCT07889908
Testing a Non-Deceptive Placebo Intervention for Subclinical Depressive Symptoms
NCT07889908, Not applicable, Not yet recruiting, Miami University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Testing a Non-Deceptive Placebo Intervention for Subclinical Depressive Symptoms. Trials, record NCT07889908. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07889908
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Testing a Non-Deceptive Placebo Intervention for Subclinical Depressive Symptoms
- NCT number
- NCT07889908
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 330 participants, estimated
- Lead sponsor
- Miami University
- Conditions
- Depression - Major Depressive Disorder, Psychological Distress, Depression / Major Depressive Disorder
- Interventions
- Non-deceptive placebo (NDP)
- First posted
- 2026-10-22
- Last updated
- 2026-10-22
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in depressive symptoms (PHQ-8) | Baseline to endpoint at 2 weeks. | Patient Health Questionnaire, 8-item depression scale (Kroenke et al., 2009). Total score range 0-24, with higher scores indicating greater depressive symptom severity. |
| Other | Treatment expectancy | Immediately after intervention delivery at the baseline session | First three items of the Treatment Expectation Questionnaire (TEX-Q; Shedden-Mora et al., 2023), corresponding to the positive treatment outcome expectation subscale: expected symptom relief, expected benefit, and expected health improvement. Each item is rated on an 11-point scale from 0 to 10, with higher scores indicating stronger positive expectations. Scored as the mean of the three items. |
| Other | Intervention acceptability | Endpoint, 2 weeks after baseline | Acceptability of Intervention Measure (AIM; Weiner et al., 2017). Four items rated from 1 (completely disagree) to 5 (completely agree), scored as the mean of the four items. Score range 1-5; higher scores indicate greater acceptability of the intervention. |
| Other | Intervention appropriateness | Endpoint, 2 weeks after baseline | Intervention Appropriateness Measure (IAM; Weiner et al., 2017). Four items rated from 1 (completely disagree) to 5 (completely agree), scored as the mean of the four items. Score range 1-5; higher scores indicate greater perceived appropriateness of the intervention. |
| Other | Intervention feasibility | Endpoint, 2 weeks after baseline | Feasibility of Intervention Measure (FIM; Weiner et al., 2017). Four items rated from 1 (completely disagree) to 5 (completely agree), scored as the mean of the four items. Score range 1-5; higher scores indicate greater perceived feasibility of the intervention. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers5
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07889908
GET https://conductscience.org/api/trials/v1/NCT07889908/registered